SELLAS Life Sciences Group Inc (NASDAQ:SLS) has a beta value of 2.28 and has seen 1.85 million shares traded in the last trading session. The company, currently valued at $147.50M, closed the last trade at $1.56 per share which meant it lost -$0.12 on the day or -7.14% during that session. The SLS stock price is -18.59% off its 52-week high price of $1.85 and 50.64% above the 52-week low of $0.77.
The consensus among analysts is that SELLAS Life Sciences Group Inc (SLS) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
Sporting -7.14% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SLS stock price touched $1.56 or saw a rise of 15.68%. Year-to-date, SELLAS Life Sciences Group Inc shares have moved 50.00%, while the 5-day performance has seen it change -10.34%. Over the past 30 days, the shares of SELLAS Life Sciences Group Inc (NASDAQ:SLS) have changed 39.29%.
Wall Street analysts have a consensus price target for the stock at $2.8, which means that the shares’ value could jump 44.29% from current levels. The projected low price target is $2.4 while the price target rests at a high of $3.2. In that case, then, we find that the current price level is -105.13% off the targeted high while a plunge would see the stock gain -53.85% from current levels.
SELLAS Life Sciences Group Inc (SLS) estimates and forecasts
The company’s shares have gained 32.20% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 45.94% over the past 5 years. Earnings growth for 2025 is a modest 15.00% while over the next 5 years, the company’s earnings are expected to increase by 42.51%.
SLS Dividends
SELLAS Life Sciences Group Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s Major holders
The top two institutional holders are VANGUARD GROUP INC with over 1.79 million shares worth more than $2.13 million. As of 2024-06-30, VANGUARD GROUP INC held 3.9862% of shares outstanding.
The other major institutional holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, with the holding of over 1.64 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.95 million and represent 3.6594% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 1.79% shares in the company for having 1.69 shares of worth $2.64 million while later fund manager owns 501.97 shares of worth $0.78 million as of Dec 31, 2024 , which makes it owner of about 0.53% of company’s outstanding stock.
